Acknowledgements
This research did not receive any specific funding from agencies or organizations in the public, commercial, or not-for-profit sectors. The authors thank Dr David Fraser (Biotech Communication SARL, Ploudalmézeau, France) for copy-editing assistance.
Authors contributions
ML, LD, MP, NS and DB designed the study; ML, LD and DB wrote the initial draft of the manuscript; LD designed the figure; JD performed the flow cytometric analysis; EKA. reported viral quantitative data; DB, MN, DC, WAC, FM and IYA reported clinical data; ML, LD, MP, PO and NS reported pharmacological data. All authors read and approved the final manuscript.
Disclosure statement
FM: Kite/Gilead (consultancy), Novartis (consultancy)
DB: Kite/Gilead (honoraria, consultancy)
The other authors declare no competing financial interests.
Data availability statement
The data that support the findings of this study are available on request from the corresponding author.